Exploring the application of immunotherapy against HIV infection in the setting of malignancy: A detailed review article
According to the Joint United Nations Programme on HIV/AIDS (UNAIDS), as of 2019, approximately 42.2 million people have died from acquired immunodeficiency syndrome (AIDS)-related illnesses since the start of the epidemic. Antiretroviral therapy (ART) has significantly reduced mortality, morbidit...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2022
|
| Subjects: | |
| Online Access: | https://doi.org/10.1016/j.intimp.2022.108580 http://hdl.handle.net/11408/5027 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1779905324898058240 |
|---|---|
| author | Makuku, Rangarirai Seyedmirzaei, Homa Tantuoyir, Marcarious M Rodríguez-Román, Eduardo Albahash, Assil Mohamed, Kawthar Moyo, Ernest Ahmed, Abdulrazaq Olamilekan Razi, Sepideh Rezaei, Nima |
| author_facet | Makuku, Rangarirai Seyedmirzaei, Homa Tantuoyir, Marcarious M Rodríguez-Román, Eduardo Albahash, Assil Mohamed, Kawthar Moyo, Ernest Ahmed, Abdulrazaq Olamilekan Razi, Sepideh Rezaei, Nima |
| author_sort | Makuku, Rangarirai |
| collection | DSpace |
| description | According to the Joint United Nations Programme on HIV/AIDS (UNAIDS), as of 2019, approximately 42.2
million people have died from acquired immunodeficiency syndrome (AIDS)-related illnesses since the start of
the epidemic. Antiretroviral therapy (ART) has significantly reduced mortality, morbidity, and incidence of the
human immunodeficiency virus (HIV)/AIDS-defining cancers, taming once-dreaded disease into a benign chronic
infection. Although the treatment has prolonged the patients’ survival, general HIV prevalence has increased and
this increase has dovetailed with an increasing incidence of Non-AIDS-defining cancers (NADCs) among people
living with HIV (PLWH). This is happening when new promising approaches in both oncology and HIV infection
are being developed. This review focuses on recent progress witnessed in immunotherapy approaches against
HIV-related, Non-AIDS-defining cancers (NADCs), and HIV infection |
| format | Article |
| id | ir-11408-5027 |
| institution | My University |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier |
| record_format | dspace |
| spelling | ir-11408-50272022-08-02T17:58:24Z Exploring the application of immunotherapy against HIV infection in the setting of malignancy: A detailed review article Makuku, Rangarirai Seyedmirzaei, Homa Tantuoyir, Marcarious M Rodríguez-Román, Eduardo Albahash, Assil Mohamed, Kawthar Moyo, Ernest Ahmed, Abdulrazaq Olamilekan Razi, Sepideh Rezaei, Nima ART immunotherapy People living with HIV HIV Cancer CAR T cell therapy According to the Joint United Nations Programme on HIV/AIDS (UNAIDS), as of 2019, approximately 42.2 million people have died from acquired immunodeficiency syndrome (AIDS)-related illnesses since the start of the epidemic. Antiretroviral therapy (ART) has significantly reduced mortality, morbidity, and incidence of the human immunodeficiency virus (HIV)/AIDS-defining cancers, taming once-dreaded disease into a benign chronic infection. Although the treatment has prolonged the patients’ survival, general HIV prevalence has increased and this increase has dovetailed with an increasing incidence of Non-AIDS-defining cancers (NADCs) among people living with HIV (PLWH). This is happening when new promising approaches in both oncology and HIV infection are being developed. This review focuses on recent progress witnessed in immunotherapy approaches against HIV-related, Non-AIDS-defining cancers (NADCs), and HIV infection 2022-08-02T17:58:23Z 2022-08-02T17:58:23Z 2022-02-01 Article 1567-5769 https://doi.org/10.1016/j.intimp.2022.108580 http://hdl.handle.net/11408/5027 en International Immunopharmacology;Vol. 105, 108580 open Elsevier |
| spellingShingle | ART immunotherapy People living with HIV HIV Cancer CAR T cell therapy Makuku, Rangarirai Seyedmirzaei, Homa Tantuoyir, Marcarious M Rodríguez-Román, Eduardo Albahash, Assil Mohamed, Kawthar Moyo, Ernest Ahmed, Abdulrazaq Olamilekan Razi, Sepideh Rezaei, Nima Exploring the application of immunotherapy against HIV infection in the setting of malignancy: A detailed review article |
| title | Exploring the application of immunotherapy against HIV infection in the setting of malignancy: A detailed review article |
| title_full | Exploring the application of immunotherapy against HIV infection in the setting of malignancy: A detailed review article |
| title_fullStr | Exploring the application of immunotherapy against HIV infection in the setting of malignancy: A detailed review article |
| title_full_unstemmed | Exploring the application of immunotherapy against HIV infection in the setting of malignancy: A detailed review article |
| title_short | Exploring the application of immunotherapy against HIV infection in the setting of malignancy: A detailed review article |
| title_sort | exploring the application of immunotherapy against hiv infection in the setting of malignancy: a detailed review article |
| topic | ART immunotherapy People living with HIV HIV Cancer CAR T cell therapy |
| url | https://doi.org/10.1016/j.intimp.2022.108580 http://hdl.handle.net/11408/5027 |
| work_keys_str_mv | AT makukurangarirai exploringtheapplicationofimmunotherapyagainsthivinfectioninthesettingofmalignancyadetailedreviewarticle AT seyedmirzaeihoma exploringtheapplicationofimmunotherapyagainsthivinfectioninthesettingofmalignancyadetailedreviewarticle AT tantuoyirmarcariousm exploringtheapplicationofimmunotherapyagainsthivinfectioninthesettingofmalignancyadetailedreviewarticle AT rodriguezromaneduardo exploringtheapplicationofimmunotherapyagainsthivinfectioninthesettingofmalignancyadetailedreviewarticle AT albahashassil exploringtheapplicationofimmunotherapyagainsthivinfectioninthesettingofmalignancyadetailedreviewarticle AT mohamedkawthar exploringtheapplicationofimmunotherapyagainsthivinfectioninthesettingofmalignancyadetailedreviewarticle AT moyoernest exploringtheapplicationofimmunotherapyagainsthivinfectioninthesettingofmalignancyadetailedreviewarticle AT ahmedabdulrazaqolamilekan exploringtheapplicationofimmunotherapyagainsthivinfectioninthesettingofmalignancyadetailedreviewarticle AT razisepideh exploringtheapplicationofimmunotherapyagainsthivinfectioninthesettingofmalignancyadetailedreviewarticle AT rezaeinima exploringtheapplicationofimmunotherapyagainsthivinfectioninthesettingofmalignancyadetailedreviewarticle |